Global Health Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 31 Jul 2026

Company page: Global Health share price, financials & guidance record

Global Health Limited delivered a strong Q1 FY27, marked by robust revenue and EBITDA growth across its network. The Noida facility showed significant improvement, with its EBITDA loss narrowing considerably, and the company continued its capacity expansion plans, including a larger Guwahati project. Management expressed confidence in its long-term growth strategy and operational efficiency.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 22.3%, net profit down 9.9% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	665	812	803	882	926 +39%	940 +16%	961 +20%	1,079 +22%
Expenses	514	611	608	688	734	766	767	849
EBITDA	150	202	195	195	193 +29%	174 −14%	193 −1%	230 +18%
Margin	23%	25%	24%	22%	21%	19%	20%	21%
Other income	24	19	-24	43	39	-11	36	24
Interest	5	8	7	6	9	13	13	16
Depreciation	25	37	38	33	37	48	52	55
Profit before tax	144	175	126	198	185 +28%	103 −41%	163 +29%	183 −8%
Tax rate	27%	25%	26%	23%	24%	22%	24%	25%
Net profit	104	131	93	152	140 +35%	80 −39%	124 +33%	137 −10%
EPS	3.89	4.89	3.48	5.65	5.22	2.97	4.62	5.11

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls